Numerous 2,5-dimethoxy-N-benzylphenethylamines (NBOMe), carrying a variety of lipophilic substituents at the 4-position, are potent agonists at 5-hydroxytryptamine (5HT2A) receptors and show hallucinogenic effects. The present study investigated the metabolism of 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using the microsomal model of pooled human liver microsomes (pHLM) and the microbial model of the fungi Cunninghamella elegans (C. elegans). Identification of metabolites was performed using liquid chromatography-high resolution-tandem mass spectrometry (LC-HR-MS/MS) with a QqToF instrument. In total, 36 25D-NBOMe phase I metabolites, 26 25E-NBOMe phase I metabolites and 24 25N-NBOMe phase I metabolites were detected and identified in pHLM. Furthermore, 14 metabolites of 25D-NBOMe, eleven 25E-NBOMe metabolites and nine 25N-NBOMe metabolites could be found in C. elegans. The main biotransformation steps observed were oxidative deamination, oxidative N-dealkylation also in combination with hydroxylation, oxidative Odemethylation possibly combined with hydroxylation, oxidation of secondary alcohols, mono-and dihydroxylation, oxidation of primary alcohols and carboxylation of primary alcohols. Additionally, oxidative di-O-demethylation for 25E-NBOMe and reduction of the aromatic nitro group and Nacetylation of the primary aromatic amine for 25N-NBOMe took place. The resulting 25N-NBOMe metabolites were unique for NBOMe compounds. For all NBOMes investigated, the corresponding 2,5-dimethoxyphenethylamine (2C-X) metabolite was detected. This study reports for the first time 25X-NBOMe N-oxide metabolites and hydroxylamine metabolites, which were identified for 25D-NBOMe and 25N-NBOMe and all three investigated NBOMes, respectively. C. elegans was capable of generating all main biotransformation steps observed in pHLM and might therefore be an interesting model for further studies of new psychoactive substances (NPS) metabolism.
Introduction:
In the last ten years, new psychoactive substances (NPS) have become a growing problem. Chatwin et al. 1 define NPS as "chemical compounds that have been modified and developed to mimic the effects of drugs which are already prohibited". Currently, the European Union (EU) Early Warning System, coordinated by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), is monitoring over 620 NPS, with one sixth of them belonging to the chemical class of phenethylamines 2, 3 . Prominent substances belonging to this class are 2C-type phenethylamines 4 , which are 2,5-dimethoxyphenethylamines, substituted at the 4-position, typically with halogens or alkyl groups, and also 2,5-dimethoxy-N-benzylphenethylamines, so called NBOMes which have emerged in recent years 5 . Substitutions on the 4-position include bromine (25B-NBOMe), chlorine (25C-NBOMe), methyl (25D-NBOMe), ethyl (25E-NBOMe), iodine (25I-NBOMe), nitro (25N-NBOMe) groups but the unsubstituted form (25H-NBOMe) is also available 6 , which has been detected as an impurity in blotter papers 7 . These substances were found to be potent 5HT2A receptor agonists [8] [9] [10] [11] . Furthermore, Braden et al. could show that the addition of the N-methoxybenzyl group to 2C-X compounds significantly increases their affinity to the 5-HT2A receptor and therefore results in higher behavioural responses 12 . NBOMes and their homologues produce psycho-and cardiovascular stimulant effects in addition to hallucinations 13 . In cases of acute drug intoxication, sympathomimetic toxicity such as tachycardia, hypertension, mydriasis, agitation, vasoconstriction and hyperthermia were observed [14] [15] [16] [17] , which could point towards serotonin syndrome. Recommended treatment in case of intoxication is heart rate, blood pressure and body temperature monitoring 18 . Furthermore, for acute treatment of sympathomimetic toxidrome, administration of benzodiazepines, fluid replacement and physical cooling should be performed to control agitation, cardiovascular stimulation and hyperthermia due to serotonin toxicity 16, 18, 19 . NBOMe compounds are usually taken in doses of 200 µg to 2000 µg (depending on the compound), mainly by sublingual application on blotter papers, and they have been reported to be sold as counterfeit LSD products 20, 21 . Several NBOMe case studies of intoxication with non-fatal 15, 16, 22 and fatal intoxication 13, 23, 24 have been reported. The presence of metabolites is proof of consumption of the parent substrate. Therefore, metabolism studies are needed to identify metabolites of NPS, which can then be used as biomarkers to confirm consumption. Another issue concerning NPS is the lack of reference standards, which can be overcome by identifying unique fingerprints of drug metabolites.
In order to form phase I and phase II metabolites, different in vivo and in vitro models are available. Human studies are ethically not favourable and therefore animal in vivo studies or in vitro alternatives are commonly used. Pooled human liver microsomes (pHLM) have been shown to be a reliable in vitro model for the generation of phase I metabolites [25] [26] [27] . An alternative to in vitro models, such as primary human hepatocytes (PHH), pooled human S9 fraction (pS9) or pHLM 28 , are microbial models of the fungus Cunninghamella elegans (C. elegans). Microbial models have the advantage of low cost, easy handling, scale-up capability and further to reduce use of animals 29 . Moreover, C. elegans has the enzymatic activity of both phase I and II enzymes 29 and holds the cytochrome P450 CYP509A1 enzyme 30 . This class of fungi has the ability to facilitate reactions such as hydroxylation, carboxylation, dihydrodiol formation, oxidative defluorination, N-dealkylation, glucuronidation and sulfation 31, 32 , as well as those catalysed by human CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 29, [32] [33] [34] . It was recently shown by Nielsen et al. 35 that the main enzymes involved in the 25I-NBOMe metabolism are CYP3A4 and CYP2D6. Caspar et al. 4 reported that for 25B-NBOMe and 25C-NBOMe the enzymes CYP1A2, CYP3A4, CYP2C9 and CYP2C19 play a crucial role.
The aim of the present study was to conduct metabolism studies of three different NBOMe analogues, 25D-NBOMe, 25E-NBOMe and 25N-NBOMe employing pHLM and C. elegans and to identify phase I metabolites based on mass spectrometric data. Besides the most common analogues 25B-NBOMe and 25I-NBOMe, the three analogues have previously been identified on confiscated blotter papers 7 . All measurements were performed using liquid chromatography-high resolution-tandem mass spectrometry (LC-HR-MS/MS) and metabolites were identified according to their precursor masses, the most abundant product ions and the isotope patterns. So far no biotransformation data are available on the three investigated NBOMes.
Materials and Methods 2.1 Chemicals and Reagents
Yeast extract, malt extract and peptone from soy beans were obtained from Carl Roth (Karlsruhe, Germany), glucose from Applichem (Darmstadt, Germany Hydrochloride salts of 25D-NBOMe (98.5 %), 25E-NBOMe (>98.5 %), and 25N-NBOMe (98.5 %), were purchased from Lipomed (Arlesheim, Switzerland). The reference standard of 25B-NBOMe-D3 (0.01 mg/mL in methanol) was obtained from Cerilliant (Round Rock, TX, USA). Formic acid (analytical grade, 98 %) and ammonium formate were obtained from Fluka (Sigma-Aldrich, Buchs, Switzerland), methanol (absolute, HPLC grade) from Biosolve (Chemie Brunschwig, Basel, Switzerland), acetonitrile (HPLC gradient grade, 99.9 %) and 1-chlorobutane (HPLC gradient grade, 99.8 %) from Acros Organics (Chemie Brunschwig, Basel, Switzerland). Direct-Q water purification system from Millipore (Zug, Switzerland) was used to produce in-house ultrapure water. All solutions and samples were handled using precision pipettes from Gilson (Mettmenstetten, Switzerland) and Socorex Isba S.A (Ecublens, Switzerland)
In Silico predictions
Prediction of possible metabolites was carried out in order to assist in the interpretation of the collected mass spectrometric data, using Meteor Nexus v.3.0.1 (Lhasa Limited). It is a knowledgebased expert system that predicts the biotransformation of a substrate 36 . Parameters were as follows: species human, processing direction breath first, maximal depth 3, absolute reasoning: minimum likelihood equivocal and relative reasoning: level of cut-off 2. Results of the in silico predictions were compared to information independent LC-HR-MS/MS measurements using the Analyst software 1.6 TF with MasterView TM Software Version 1.1 with the extracted ion current (XIC) tool.
Microsomal assay using pHLM
For generating phase I metabolites, microsomal in vitro experiments were performed as previously published 27 . Briefly, the following components were mixed in a reaction tube, with a final volume of 50 µL and indicated concentrations are final concentrations: deionized water, potassium phosphate buffer (100 mM), magnesium chloride (5 mM), superoxide dismutase (200 units/mL), NADPHregenerating solution A (NADP+ and glucose-6-phosphate) and B (glucose-6-phosphate dehydrogenase), pHLM (1 mg/mL) and a reference standard of one of the three investigated NBOMes (25 µM). Samples were incubated for 60 min at 37 °C, which is an commonly reported incubation time in literature. Simultaneously, blanks containing no drug substrates and negative controls containing no pHLM were prepared. The reactions were stopped by adding 50 µL ice cold acetonitrile containing an internal standard of 25B-NBOMe-D3. After mixing, the samples were centrifuged at 17' 000 g and 8 °C for 10 min and the supernatants transferred to autosampler vials. The samples were evaporated to dryness at 50 °C under nitrogen and reconstituted in 50 µL water/acetonitrile/formic acid, (95:5:0.1; v/v/v). Experiments were conducted in triplicates.
Microbial assay using fungi C. elegans
The growth medium was prepared according to the DSMZ Medium 186 (Leibniz Institute DSMZ -German Collection of Microorganisms and Cell Cultures) 37 . The media components containing yeast extract (3 g/L), malt extract (3 g/L) and peptone from soy beans (5 g/L) (solution A, without agar) and glucose (10 g/L) (solution B) were dissolved separately in deionized water. After autoclaving both solutions were mixed. For the cultivation of C. elegans, the medium (30 mL) was inoculated with a piece of mycelium from the agar plate. The culture flasks were shaken for three days at 100 rpm at 28 °C on a rotary shaker (KS 260 basic, IKA-Werke GmbH & Co. Kg, Staufen im Breisgau, Germany). On day three, the C. elegans biomasses were transferred to new flasks containing fresh medium and were again inoculated with a piece of mycelium. This way, two different growth stadiums of the fungi biomasses were obtained, which increased the ability of the fungi to metabolise. Solutions of each NBOMe were prepared in 70 % ethanol with concentrations of 50 µM. On day four, 800 µL of NBOMe solution was added to the culture flask and incubated for 72 hours by shaking at 100 rpm at 28 °C. In preliminary experiments, the incubation time was evaluated for time points 24, 48, 72 and 96 hours. Results showed that 72 and 96 hours of incubation resulted equally in the most amount of metabolites, therefore 72 hours were chosen as incubation time. After three days, the reaction was stopped and the growth medium and the fungi biomass stored separately in 30 mL falcon tubes at -20 °C, this stops the fungi's ability to further metabolise. Samples were stored at -20 °C until they were processed. Experiments were carried out in duplicates. In preliminary experiments, the growth medium has been analysed but only the parent compounds were detected. The reason for this is that the fungi only takes up the substrates in the growth medium but does not release the formed metabolites back to it. Therefore, for the detection and identification of metabolites in the fungi biomass was intensively analysed. Additionally, this made it necessary to homogenize the fungi biomass.
Extractions were performed as follows: on average, 1.10 g (range 1.03-1.15 g) fungi biomass were weighed into a homogenization tube (gentleMacs M Tubes, Macs Miltenyi Biotec, Bergisch Gladbach, Germany), and 4 mL of phosphate puffer pH 9 added. The fungi sample was homogenized with a gentle Macs Dissociator, using a pre-programmed gradient of 45 seconds. One mL of the fungi solution was then transferred to a new vial and 10 µL internal standard 25B-NBOMe-D3 (2000 ng/mL) and 1.5 mL 1-chlorobutane added. Afterwards, the sample was mixed for at least 10 min followed by centrifugation for 10 min at 17' 000 g rpm at 8 °C. The supernatant was then transferred to an autosampler vial and evaporated under nitrogen at 50 °C. Finally, the sample was reconstituted in 100 µL water/acetonitrile/formic acid (95:5:0.1; v/v/v).
LC-HR-MS/MS analysis
All samples were analysed using a Dionex Ultimate 3000 HPLC system (Thermo Fisher Scientific, Reinach, Switzerland) coupled to a 5600 TripleTof System equipped with a DuoSpray interface and Analyst software 1.6 TF with MasterView TM Software Version 1.1 (Sciex, Toronto, Canada). For data evaluation, the following parameters were chosen: a cut-off mass error of 5 ppm, intensities higher than 500 cps and only peaks eluting in the gradient within 2 and 22 min. Chromatographic separation was performed on a reversed phase Kinetex C8 column, 2. The injection volume was 1.0 µL. The MS parameters were as follows: ESI voltage 5.0 kV, source temperature 650 °C, curtain gas 55 arbitrary units, gas 1 and 2 at 55 arbitrary units. All data were acquired in positive ion mode. Information dependent data acquisition (IDA) was carried out using a survey scan from m/z 100 to 950, triggering the acquisition of product ion mass spectra for the nine most abundant precursor ions in a mass range from m/z 50 to 950. For dependent and survey scans the accumulation time was set to 40 ms and 50 ms, respectively. The collision energy was set to 35 eV and a collision energy spread of ± 15 eV. The SCIEX QqToF system used is automatically calibrated at the start of every new chromatogram by injection of a calibration solution directly in the ion source (post-column).
Results and Discussion
In order to exclude matrix peaks as potential metabolites, all data obtained were compared to blank pHLM and fungi samples, containing the matrix but no drug and negative control samples containing 
Identification of metabolites
The molecular structure of 25X-NBOMe compounds and metabolites can be divided into two parts: the 4-substituted 2,5-dimethoxyphenethylamine is referred as the 2C part and the N-(2methoxybenzyl) is the so called NBOMe part 4 . Figure 7 presents the nomenclature used for the description of fragmentation and positions of metabolisation. A large number of metabolites was identified for each 25X-NBOMe and therefore only the characteristic product ions used for identification will be discussed in detail. Representative product ion mass spectra of metabolites for each 25X-NBOMe are displayed in Figure 8 . All other mass spectra can be found in the supporting information. The parent compounds and their metabolites were identified by precursor ion masses of the respective protonated molecule, their most abundant product ions and isotope pattern, and for those metabolites occurring in both pHLM and the fungi C. elegans, by their retention times. The protonated masses and product ions given are the calculated values.
For the 25X-NBOMe parent compounds, the respective precursor ions and the product ions with m/z 121.0653 and m/z 91.5048 (representing the NBOMe part) were present. The product ions resulted due to amine cleavage of the NBOMe moiety forming [C8H9O] + (m/z 121.0653) and further demethoxylation via neutral loss of formaldehyde forming the tropylium ion [C7H7] + (m/z 91.0548) 38 . These product ions were consistent with previously published data on 25B-NBOMe, 25C-NBOMe and 25I-NBOMe, because the alterations between the 25X-NBOMe are on the 2C part at the 4-position 4, . All other product ions were specific to the 2C part and are discussed in the following paragraphs.
25D-NBOMe
Thirty-six distinctive 25D-NBOMe metabolites were identified in pHLM and 14 in fungi C. elegans. The fragmentation of the parent compound 25D-NBOMe (C19H25NO3 precursor ion M+H + m/z 316.1907) resulted in product ions with m/z 179.1072, m/z 121.0653, m/z 91.0538 and the protonated molecule with m/z 316.1900. This product ion represented amine cleavage forming [C11H15O2] + , and the last two are specific for the intact NBOMe part. These product ions can be used among others for identifying metabolites in combination with previously mentioned product ions. When a product ion with m/z 179.1072 ([C11H15O2] + ) was present no biotransformation took place on the 2C part but was possible on the amine. An intact 2,5-dimethoxy-1,4-dimethyl cation was identified with a product ion with m/z 165.0916 ([C10H13O2] + ). The three O-demethylated metabolites (D7-D9: C18H23NO3 precursor ion M+H + m/z 302.1751) were differentiated depending on following product ions (besides the precursor ions and product ions): the occurrence of the product ions m/z 121.0653 and m/z 91.0548 characteristic for the NBOMe part means that O-demethylation occurs on the 2C part, and a product ion of m/z 107.0497 ([C7H7O] + ) means that O-demethylation takes place on the NBOMe moiety. The mono-hydroxylated in combination with O-demethylated metabolites (D10-D19: C18H23NO4 precursor ion M+H + m/z 318.1700) were identified as follows: The mass spectrum of metabolite D10 only displays two product ions which are typical for an intact NBOMe part. Therefore, the only statement that can be made is that both O-demethylation and hydroxylation occur on the 2C part. Due to the lack of fragmentation and since tertiary hydrocarbons are preferred over secondary hydrocarbons as site of hydroxylation, it is more likely that hydroxylation occurs on the 2,5-dimethoxy-4-dimethyl 40 . The fragmentation of D11 displays the loss of a water molecule from the precursor ion forming m/z 300.1600 ([C18H22NO3] + ), which correlates with a rearrangement forming a double bound. Furthermore, the two characteristic NBOMe part product ions are present, which indicate that biotransformation must have occurred on the 2C part. 
25E-NBOMe

Microsomal biotransformation
Incubation of pHLM with 25D-NBOMe, 25E-NBOMe and 25N-NBOMe resulted in 36, 26 and 24 metabolites, respectively. Several different biotransformational mechanisms were observed in all three 25X-NBOMe compounds. Hydroxylation of the parent substrate (+15.995 Da) formed six 25D-NBOMe metabolites (D21-D26), five 25E-NBOMe metabolites (E21-E25) and three 25N-NBOMe metabolites (N22-N24). Hydroxylation of the parent compound was observed at α-position for D22, E21 and E22, β-or α-position for D23, D25 and α-position or on the amine for D26, E23, E25 and N22. D23, D25 and N22 were further metabolised by oxidation of the secondary alcohol forming D20 and N20. For both D24 and E24 hydroxylation was identified to be on the vicinal position. Two Noxide metabolites were observed (D27/ N21) both eluting after the parent substrates, which is typical for N-oxides on reversed phase columns 27, 41 . The resulting mono-hydroxylated metabolites underwent further oxidative O-demethylation (D10-D19/ E12-E19/ N15-N18; mass difference to parent substrate -14.0157 Da) on the 2C part (D10-D12, D14, D15, D17, D19/ E12-E16, E19/ N16) or on the NBOMe part (D16/ E17 / N15, N17, N18). Oxidative O-demethylation of the parent compound (mass difference to parent -14.0156 Da) on either the 2 nd or 5 th position of the 2C part or 2 nd position on the NBOMe part was observed for all three compounds resulting in three metabolites (D7/ E8/ N12; D8/ E7/ N13; D9/ E9/ N14;). Further oxidative O-demethylation (mass difference to parent substrate -28.0312 Da) of these metabolites resulted in metabolites found for all three tested 25X-NBOMes (D4/ E6/ N9; D5/ E5/ N10; D6/ N11;). Only for E6 further metabolisation occurred, forming a di-O-demethylated and hydroxylated metabolite E10 and E11. For all three substrates, the respective 2,5-dimethoxyphenethylamine (2C-X) metabolites could be identified (D2, E3, N3) formed by oxidative N-dealkylation (-120.0575 Da). 2C-X are also biologically active compounds used for recreational purposes and have been previously identified as 25B-NOMe and 25I-NBOMe metabolites 4 . This 2C-X metabolite was further metabolised by oxidative deamination forming 2methoxybenzoic acid (D1/ E1/ N1; precursor ion M+H + m/z 153.0546), identical for all three substrates. In summary, the observed biotransformation pathways of 25D-NBOMe were oxidative Odeamination, oxidative N-dealkylation also in combination with hydroxylation, oxidative Odemethylation possibly combined with hydroxylation, oxidation of secondary alcohols, mono-and dihydroxylation, oxidation of primary alcohols and carboxylation of primary alcohols. For 25E-NBOMe the same metabolism steps were observed differing in the sites of metabolic modifications. Additionally, oxidative di-O-demethylation was seen. 25N-NBOME metabolism was very similar to 25D-NBOMe and 25E-NBOMe, with mostly the same steps observed. In addition, due to the presence of the aromatic nitro group, the following mechanisms were observed: reduction of the aromatic nitro group, also in combination with demethylation and N-acetylation of the primary aromatic amine.
Meteor Nexus was a helpful aid in the evaluation of obtained IDA-LC-HR-MS/MS data in combination with the MasterView TM software. Nevertheless, a critical interpretation of data is necessary using described parameters. Every hit passing this criterion must then be manually checked if the peak was a peak or simply noise and if the isotopic ratio was correct. The mass spectra are then used to unambiguously identify a metabolite. Only 19 metabolites were not predicted by Meteor Nexus but identified by the authors using the gained knowledge about typical fragmentation patterns. Therefore, the in silico predictions provided by Meteor Nexus are a valuable tool for data evaluation but nevertheless need to be assessed critically.
Caspar et al. 4 reported 35 phase I metabolites of 25B-NBOMe of which 13 followed the same biotransformation pathways as 35 metabolites of the 90 metabolites found for 25D-NBOMe, 25E-NBOMe and 25N-NBOMe. N-oxides and hydroxylamines of 25X-NBOMes were identified in the present study , which have not yet been reported in literature.
Microbial biotransformation
Microbial experiments incubations of 25D-NBOMe, 25E-NBOMe or 25N-NBOMe with C. elegans generated 14, 11 and 9 metabolites, respectively. Each metabolite found in fungi was also identified in pHLM. Metabolites were identified according to their precursor ion, fragmentation , isotope ratios and retentions times, which were the same as for the metabolites found in previous experiments with pHLM. Biotransformation steps observed in fungi C. elegans were oxidative N-dealkylation, oxidative O-demethylation also in combination with hydroxylation, oxidation of secondary alcohols and mono-and di-hydroxylation for all three compounds, and for 25N-NBOMe additionally reduction of the aromatic nitro groups and N-hydroxylation of secondary aliphatic amines. For 25D-NBOMe and 25N-NBOMe also N-oxide formation and hydroxylamine metabolites were identified.
The microsomal method of pHLM generated three times more metabolites than the microbial method of the fungi C. elegans. Watanabe et al. 32 reported to have found more metabolites of JWH-018 and other similar synthetic cannabinoids, in C. elegans than literature data reports found in pHLM. But Watanabe et al. used a different C. elegans line, which could explain different results. The ability of the fungi C. elegans to metabolise xenobiotics and especially NPS could depend on the chemical class of the drug. Therefore, it is advised to conduct more metabolism studies with C. elegans, investigating different chemical classes of NPS, in order to be able to conclude the fungi's ability to be a good metabolism model.
Conclusion
Microsomal and microbial experiments resulted in thirty-six 25D-NBOMe phase I metabolites, twenty-six 25E-NBOMe phase I metabolites and twenty-four 25N-NBOMe phase I metabolites. One metabolite identical for all three compounds was found (E1/ D1/ N1). For the first time, an N-oxide 25X-NBOMe metabolite was identified, namely D27 and N21, which eluted 0.91 min and 1.66 min after the parent substrate, respectively. Additionally, hydroxylamine metabolites were identified due to their fragmentation (D11, D12, D17, D26, D33; E12, E13, E14, E19, E23, E25; N22). For 25N-NBOMe unique metabolites were detected due to the reduction of the aromatic nitro group. Main biotransformation steps observed were oxidative O-demethylation, mono and dihydroxylation, Noxide formation, hydroxylamine formation and N-dealkylation. Additionally, metabolites found in both pHLM and fungi C. elegans were eluting at the same retention times and could therefore be identified according their retention times. The fungi C. elegans could generate all main phase I biotransformation steps observed for all three compounds and therefore is an interesting model for further studies of NPS metabolism. Nevertheless, in the current study no phase II metabolites were identified in the fungi C. elegans samples. When authentic biological samples of consumers of 25D-NBOMe, 25E-NBOMe or 25N-NBOMe are available, these metabolites can be used for target analysis, and might confirm the predictions from in-vitro experiments to some extent. Additionally, phase II metabolites (e.g. glucuronides) might be present in urine samples, which might have similar mass spectrometric product ions.
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